JPS6317850A
(ja)
|
1986-07-11 |
1988-01-25 |
Fuji Photo Film Co Ltd |
3−フエノキシカテコ−ル類の製造方法
|
NZ231631A
(en)
|
1988-12-08 |
1992-07-28 |
Duphar Int Res |
Heterocyclically-substituted piperazine and diazepine derivatives and anxiolytic compositions
|
JPH02255674A
(ja)
|
1989-03-27 |
1990-10-16 |
Fuji Photo Film Co Ltd |
4―アリールオキシ―1,3―ベンゾジオキソール類およびその製造方法
|
JPH02255673A
(ja)
|
1989-03-27 |
1990-10-16 |
Fuji Photo Film Co Ltd |
4―アリールオキシー1,3―ベンゾジオキソール類およびその製造方法
|
JPH02269352A
(ja)
|
1989-04-10 |
1990-11-02 |
Fuji Photo Film Co Ltd |
感光材料
|
JP2537682B2
(ja)
|
1989-04-21 |
1996-09-25 |
富士写真フイルム株式会社 |
3―アリ―ルオキシカテコ―ル類の製造方法
|
US5296497A
(en)
|
1989-05-16 |
1994-03-22 |
Duphar International Research B.V. |
3,4-dehydropiperidine derivatives having psychotropic activity
|
JPH03130280A
(ja)
|
1989-10-17 |
1991-06-04 |
Fuji Photo Film Co Ltd |
4―アリールオキシ―1,3―ベンゾジオキソール類の製造方法
|
JP2816492B2
(ja)
|
1990-05-23 |
1998-10-27 |
コニカ株式会社 |
ハロゲン化銀写真感光材料
|
JPH0446175A
(ja)
|
1990-06-14 |
1992-02-17 |
Fuji Photo Film Co Ltd |
5―ヒドロキシ―3,4―メチレンジオキシ安息香酸誘導体の製造法
|
JPH0641038A
(ja)
|
1992-07-17 |
1994-02-15 |
Mitsubishi Kasei Corp |
カルボン酸誘導体
|
DE4326151A1
(de)
|
1993-08-04 |
1995-02-09 |
Hoechst Ag |
Aromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
|
US5629200A
(en)
|
1993-11-18 |
1997-05-13 |
Daicel Chemical Industries, Ltd. |
Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
|
US5514505A
(en)
|
1995-05-15 |
1996-05-07 |
Xerox Corporation |
Method for obtaining improved image contrast in migration imaging members
|
DE69739970D1
(de)
|
1996-01-29 |
2010-10-07 |
Univ California |
Methode zur behandlung sexueller fehlfunktionen
|
US5968929A
(en)
|
1996-10-30 |
1999-10-19 |
Schering Corporation |
Piperazino derivatives as neurokinin antagonists
|
JPH10287654A
(ja)
|
1997-04-11 |
1998-10-27 |
Nissan Chem Ind Ltd |
ピラゾロン誘導体及び除草剤
|
US6166008A
(en)
|
1997-10-27 |
2000-12-26 |
Cortex Pharmaceuticals, Inc. |
Treatment of schizophrenia with ampakines and neuroleptics
|
UA72749C2
(en)
|
1998-09-29 |
2005-04-15 |
White Holdings Corp |
Substituted 3-cyanoquinolines, a method for the preparation thereof (variants), pharmaceutical composition based thereon, a method for the treatment, inhibiting the growth or elimination of neoplasms and a method for the treatment, inhibiting progressing or elimination of polycystic kidney disease using them
|
EP1384713B1
(en)
*
|
1998-12-23 |
2008-10-15 |
SmithKline Beecham Corporation |
4-amino-azepan-3-one derivatives as protease inhibitors
|
US7977333B2
(en)
|
2000-04-20 |
2011-07-12 |
Bayer Healthcare Llc |
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
|
US6451814B1
(en)
|
2000-07-17 |
2002-09-17 |
Wyeth |
Heterocyclic β-3 adrenergic receptor agonists
|
PL202812B1
(pl)
|
2000-08-21 |
2009-07-31 |
Astrazeneca Ab |
Pochodna chinazoliny, jej kompozycja famaceutyczna oraz jej zastosowanie
|
AU2001281246A1
(en)
|
2000-08-23 |
2002-03-04 |
The Procter And Gamble Company |
Benzimidazoles and analogues and their use as neutrophil inhibitors
|
PT2264018E
(pt)
|
2000-08-24 |
2015-06-03 |
Univ Pittsburgh |
Derivados de tioflavina para uso no diagnóstico da doença de alzheimer
|
AUPR255401A0
(en)
|
2001-01-16 |
2001-02-08 |
Novogen Research Pty Ltd |
Regulation of lipids and/or bone density and compositions therefor
|
JP4256679B2
(ja)
|
2001-03-16 |
2009-04-22 |
ノボゲン リサーチ ピーティーワイ リミテッド |
再狭窄の治療方法
|
ES2278016T3
(es)
|
2001-04-09 |
2007-08-01 |
Novartis Vaccines And Diagnostics, Inc. |
Compuestos guanidino como agonistas del receptor de melanocortina 4 (mc4-r).
|
EP1381599B1
(en)
|
2001-04-19 |
2008-09-24 |
Astrazeneca AB |
Quinazoline derivatives
|
DE10148618B4
(de)
|
2001-09-25 |
2007-05-03 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
DE10148617A1
(de)
|
2001-09-25 |
2003-04-24 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
AUPR846401A0
(en)
|
2001-10-25 |
2001-11-15 |
Novogen Research Pty Ltd |
6-Hydroxy isoflavones, derivatives and medicaments involving same
|
JP4361800B2
(ja)
|
2001-12-21 |
2009-11-11 |
サイトキネティックス, インコーポレイテッド |
心不全を処置するための組成物および方法
|
EP1463719A2
(en)
|
2002-01-08 |
2004-10-06 |
Eisai Co., Ltd |
Eponemycin and epoxomicin analogs and uses thereof
|
AU2003214873A1
(en)
|
2002-01-18 |
2003-09-02 |
Ceretek Llc |
Methods of treating conditions associated with an edg receptor
|
US7196108B2
(en)
|
2002-03-08 |
2007-03-27 |
Incyte San Diego Inc. |
Bicyclic heterocycles for the treatment of diabetes and other diseases
|
MXPA04009896A
(es)
|
2002-04-09 |
2005-06-17 |
Novogen Res Pty Ltd |
Metodos terapeuticos y composiciones que implican estructuras de tipo isoflav-3-eno e isoflavano.
|
DE10219294A1
(de)
|
2002-04-25 |
2003-11-13 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
AU2003250117B2
(en)
|
2002-07-29 |
2007-05-10 |
F. Hoffmann-La Roche Ag |
Novel benzodioxoles
|
AU2002951271A0
(en)
|
2002-09-06 |
2002-09-19 |
Novogen Research Pty Ltd |
Repair of dna mutagenic damage
|
JP2006508058A
(ja)
|
2002-09-23 |
2006-03-09 |
ノボジェン・リサーチ・プロプライエタリー・リミテッド |
皮膚光老化および光線性損傷の治療
|
EP1648452B1
(en)
|
2003-07-28 |
2009-07-22 |
Merck Serono SA |
2-imino-4-(thio)oxo-5-polycyclovinylazolines for use as pi3 kinase inhibitors
|
KR101153335B1
(ko)
|
2003-09-24 |
2012-07-05 |
메틸진 인코포레이티드 |
히스톤 데아세틸라제의 억제제
|
US20070244075A1
(en)
|
2003-11-18 |
2007-10-18 |
Novogen Research Pty Ltd |
Isoflavonoid Prodrugs, Compositons Thereof and Therapeutic Methods Involving Same
|
JP2007525485A
(ja)
|
2003-11-19 |
2007-09-06 |
ノボゲン リサーチ ピーティーワイ リミテッド |
複合的な放射線治療及び化学治療の組成物及び方法
|
BRPI0520812A2
(pt)
|
2004-01-16 |
2009-10-06 |
Wyeth Corp |
método para preparar um composto de quinolina 4-substituìda, e, composto
|
EP1740547A1
(en)
|
2004-04-07 |
2007-01-10 |
Millennium Pharmaceuticals, Inc. |
Pgd2 receptor antagonists for the treatment of inflammatory diseases
|
US20050245529A1
(en)
|
2004-04-14 |
2005-11-03 |
Boehringer Ingelheim International Gmbh |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
EP1751124A4
(en)
|
2004-05-07 |
2010-04-14 |
Exelixis Inc |
RAF MODULATORS AND METHODS OF USE
|
EP1753428A4
(en)
|
2004-05-14 |
2010-09-15 |
Abbott Lab |
INHIBITORS OF KINASES AS THERAPEUTIC AGENTS
|
ITMI20041347A1
(it)
|
2004-07-05 |
2004-10-05 |
Italfarmaco Spa |
Derivati di alfa-amminoacidi ad attivita'antiinfiammatoria
|
SE0401971D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Piperidne derivatives
|
ZA200702435B
(en)
|
2004-10-12 |
2008-06-25 |
Serono Lab |
PI3 Kinase gamma inhibitors for the treatment of anaemia
|
SE0402635D0
(sv)
|
2004-10-29 |
2004-10-29 |
Astrazeneca Ab |
Chemical compounds
|
JP2006145294A
(ja)
|
2004-11-17 |
2006-06-08 |
Univ Nagoya |
蛍光標識を行うラベル化試薬、リガンドを表面にもつ基材の製造方法及びラベル化試薬を用いた測定方法
|
US7524870B2
(en)
|
2004-12-03 |
2009-04-28 |
Hoffmann-La Roche Inc. |
Biaryloxymethylarenecarboxylic acids as glycogen synthase activators
|
ME01222B
(me)
|
2005-02-28 |
2013-06-20 |
Eisai R&D Man Co Ltd |
Nova kombinovana upotreba jedinjenja sulfonamida u liječenju kancera
|
US20060223846A1
(en)
|
2005-03-08 |
2006-10-05 |
Dyatkin Alexey B |
Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
|
WO2006103449A2
(en)
|
2005-03-31 |
2006-10-05 |
Astrazeneca Ab |
Saminopyrimidine derivates with tie2 inhibiting activity
|
JP2008535843A
(ja)
|
2005-04-08 |
2008-09-04 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
ピリミジン誘導体
|
CA2960117C
(en)
|
2005-05-17 |
2018-01-30 |
Sarcode Bioscience Inc. |
Lfa-1 antagonists for the treatment of eye disorders
|
EP1883621A2
(en)
|
2005-05-25 |
2008-02-06 |
Wyeth |
Methods of preparing 3-cyano-quinolines and intermediates made thereby
|
JPWO2006129609A1
(ja)
|
2005-05-30 |
2009-01-08 |
塩野義製薬株式会社 |
2−ナフチルイミノ−5,5−ジ置換−1,3−チアジン誘導体
|
WO2006130403A1
(en)
|
2005-06-02 |
2006-12-07 |
Bayer Cropscience Ag |
Phenylalkyl substituted heteroaryl devivatives
|
WO2006138418A2
(en)
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Improvement of cognitive performance with sirtuin activators
|
KR101589551B1
(ko)
|
2005-07-15 |
2016-02-02 |
알바니 몰레큘라 리써치, 인크. |
아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
|
AU2006272698B2
(en)
|
2005-07-21 |
2012-11-01 |
Paratek Pharmaceuticals, Inc. |
10-substituted tetracyclines and methods of use thereof
|
ATE539753T1
(de)
|
2005-08-04 |
2012-01-15 |
Janssen Pharmaceutica Nv |
Pyrimidin-verbindungen als serotonin-rezeptor- modulatoren
|
WO2007020936A1
(ja)
|
2005-08-17 |
2007-02-22 |
Daiichi Sankyo Company, Limited |
抗真菌作用二環性複素環化合物
|
WO2007081630A2
(en)
|
2005-12-21 |
2007-07-19 |
Janssen Pharmaceutica, N.V. |
Substituted pyrimidinyl kinase inhibitors
|
CN101007798B
(zh)
|
2006-01-24 |
2011-01-26 |
中国人民解放军军事医学科学院毒物药物研究所 |
苯并间二氧杂环戊烯衍生物及其制备方法和医药用途
|
NZ571271A
(en)
|
2006-03-23 |
2011-10-28 |
Biota Europe Ltd |
The use of benzamide or pyridinamide derivatives as antibacterial agents
|
PL2032575T3
(pl)
|
2006-05-30 |
2010-09-30 |
Neurosearch As |
Nowa pochodna oksadiazolylu, 1,4-diaza-bicyklo[3.2.2]nonylu i jej medyczne zastosowanie
|
WO2008027648A2
(en)
|
2006-06-26 |
2008-03-06 |
Case Western Reserve University |
Methods and compositions for treating pathologies associated with bdnf signaling
|
WO2008029168A2
(en)
|
2006-09-08 |
2008-03-13 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
AU2007314141A1
(en)
|
2006-10-30 |
2008-05-08 |
Novogen Research Pty Ltd |
Prevention and reversal of chemotherapy-induced peripheral neuropathy
|
RU2333211C1
(ru)
|
2006-11-01 |
2008-09-10 |
Институт физиологически активных веществ Российской Академии наук |
N,n`-замещенные 3, 7-диазабицикло[3.3.1]нонаны, обладающие фармакологической активностью, фармацевтические композиции на их основе и способ их применения
|
JP2010526825A
(ja)
|
2007-05-10 |
2010-08-05 |
エーエムアール テクノロジー インコーポレイテッド |
アリール置換およびヘテロアリール置換テトラヒドロベンゾ−1,4−ジアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用
|
BRPI0704074B8
(pt)
|
2007-08-29 |
2021-05-25 |
Univ Estadual Paulista Julio De Mesquita Filho Unesp |
derivados piperidínicos da (-)-cassina e (-)-spectalina, composições farmacêuticas contendo os mesmos e processos para sua preparação
|
WO2009054914A1
(en)
|
2007-10-19 |
2009-04-30 |
Sarcode Corporation |
Compositions and methods for treatment of diabetic retinopathy
|
WO2009136995A2
(en)
|
2008-04-16 |
2009-11-12 |
Portola Pharmaceuticals, Inc. |
Inhibitors of syk protein kinase
|
US8188287B2
(en)
|
2008-06-23 |
2012-05-29 |
Janssen Pharmaceutica N.V. |
Piperidyl acrylamide antagonists of CCR2
|
WO2010019772A2
(en)
|
2008-08-14 |
2010-02-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Oxadiazole-2-oxides as antischistosomal agents
|
JP2010254629A
(ja)
|
2009-04-27 |
2010-11-11 |
Bayer Cropscience Ag |
光学活性アゾリン誘導体
|
JP5624560B2
(ja)
|
2009-05-28 |
2014-11-12 |
大塚製薬株式会社 |
ストレス性疾患の治療のための複素環化合物
|
CA2767474A1
(en)
|
2009-07-10 |
2011-01-13 |
Vivalis |
Substituted pyrrolidinone as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use
|
RU2417082C2
(ru)
|
2009-07-14 |
2011-04-27 |
Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран) |
Средство для восстановления утраченной памяти в норме и патологии у пациентов всех возрастных групп на основе n, n'-замещенных 3, 7-диазабицикло[3.3.1]нонанов, фармацевтическая композиция на его основе и способ ее применения
|
CA2784746A1
(en)
|
2009-12-17 |
2011-07-14 |
The Lubrizol Corporation |
Lubricating composition containing an aromatic compound
|
ES2644804T3
(es)
|
2010-01-27 |
2017-11-30 |
Ab Pharma Ltd |
Compuestos poliheterocíclicos como inhibidores de HCV
|
CN101851218B
(zh)
|
2010-04-27 |
2014-10-15 |
沈阳药科大学 |
4,5-二取代芳基异硒唑类衍生物及其用途
|
WO2011156775A2
(en)
|
2010-06-10 |
2011-12-15 |
Afraxis, Inc. |
8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
|
ES2526124T3
(es)
|
2010-06-16 |
2015-01-07 |
Cymabay Therapeutics, Inc. |
Agonistas del receptor GPR120 y sus usos
|
US20130123367A1
(en)
|
2010-07-28 |
2013-05-16 |
Medizinische Universitat Wien |
Vinylogous chalcone derivatives and their medical use
|
US9132136B2
(en)
|
2010-08-02 |
2015-09-15 |
Hoffmann-La Roche Inc. |
Pharmaceutical combination
|
US8729271B2
(en)
|
2010-09-17 |
2014-05-20 |
Taisho Pharmaceutical Co., Ltd |
Glycine transporter inhibiting substances
|
WO2012045196A1
(en)
|
2010-10-09 |
2012-04-12 |
Abbott Laboratories |
Phosphoglycerate kinase inhibitors
|
US8802673B2
(en)
|
2011-03-24 |
2014-08-12 |
Hoffmann-La Roche Inc |
Heterocyclic amine derivatives
|
WO2013025484A1
(en)
|
2011-08-12 |
2013-02-21 |
Lapchak Paul A |
Polyphenol analogs to treat ischemia
|
US8791108B2
(en)
|
2011-08-18 |
2014-07-29 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
JPWO2013065835A1
(ja)
|
2011-11-04 |
2015-04-02 |
味の素株式会社 |
糖尿病治療用医薬組成物
|
WO2013120104A2
(en)
|
2012-02-10 |
2013-08-15 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
WO2013142712A1
(en)
|
2012-03-21 |
2013-09-26 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
RU2509770C2
(ru)
|
2012-06-22 |
2014-03-20 |
Общество с ограниченной ответственностью "Молекулярные Технологии" |
Новые химические соединения производные 2,4-диамино-1,3,5-триазина для профилактики и лечения заболеваний человека и животных
|
RU2015111206A
(ru)
|
2012-08-30 |
2016-10-20 |
Ниппон Синяку Ко., Лтд. |
Пиридиновое производное и лекарственное средство
|
WO2014066435A1
(en)
|
2012-10-22 |
2014-05-01 |
City Of Hope |
Etp derivatives
|
RU2015143526A
(ru)
|
2013-03-13 |
2017-04-19 |
Бостон Байомедикал, Инк. |
Производные 3-(арил или гетероарил)метилениндолин-2-она в качестве ингибиторов киназного пути раковых стволовых клеток для лечения рака
|
US20160108031A1
(en)
|
2013-04-30 |
2016-04-21 |
Heinrich-Heine-Universitat Dusseldorf |
Inhibitors of nhr2 and/or runx1/eto-tetramerization
|
KR20150027922A
(ko)
|
2013-09-04 |
2015-03-13 |
주식회사 대웅제약 |
신규한 항진균성 피리디닐하이드라자이드 유도체
|
US10011627B2
(en)
|
2013-09-09 |
2018-07-03 |
Youngene Therapeutics Co., Ltd |
C-aryl glucoside derivative, preparation methods thereof, and medical applications thereof
|
WO2015069110A1
(en)
|
2013-11-07 |
2015-05-14 |
Aapa B.V. |
Multiple d2 a(nta)gonists/h3 antagonists for treatment of cns-related disorders
|
PT3121175T
(pt)
|
2014-03-17 |
2020-03-05 |
Daiichi Sankyo Co Ltd |
Derivados de 1,3-benzodioxol como inibidores de ezh1 e/ou ezh2
|
WO2015193765A1
(en)
|
2014-06-17 |
2015-12-23 |
Pfizer Inc. |
Substituted dihydroisoquinolinone compounds
|
US10214521B2
(en)
|
2014-09-11 |
2019-02-26 |
Piramal Enterprises Limited |
Fused heterocyclic compounds as GPR120 agonists
|
WO2016130396A1
(en)
*
|
2015-02-13 |
2016-08-18 |
Constellation Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
ES2828961T3
(es)
|
2015-07-30 |
2021-05-28 |
Daiichi Sankyo Co Ltd |
Agente terapéutico y/o profiláctico para leucemia/linfoma de células T del adulto
|
CN107428742B
(zh)
|
2015-11-19 |
2020-05-08 |
江苏恒瑞医药股份有限公司 |
苯并呋喃类衍生物、其制备方法及其在医药上的应用
|
MX2018008644A
(es)
|
2016-01-13 |
2018-11-19 |
Gruenenthal Gmbh |
Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espir o-[4.5]-decano.
|
KR102486298B1
(ko)
|
2016-02-09 |
2023-01-06 |
인벤티스바이오 엘엘씨 |
인돌아민-2,3-디옥시게나아제(ido)의 억제제
|
US20170355708A1
(en)
*
|
2016-06-09 |
2017-12-14 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
ES2930092T3
(es)
|
2016-07-14 |
2022-12-07 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
CN106727549A
(zh)
|
2016-11-26 |
2017-05-31 |
李�荣 |
一种治疗抑郁症的药物
|
TW201831181A
(zh)
|
2017-01-19 |
2018-09-01 |
日商第一三共股份有限公司 |
用以用於治療htlv-1相關脊髓病之醫藥組成物
|
US11466020B2
(en)
|
2017-03-17 |
2022-10-11 |
Cornell University |
Compounds and compositions for inhibition and elimination of Zika infection and uses for same
|
CN110869358A
(zh)
|
2017-05-25 |
2020-03-06 |
亚瑞克西斯制药公司 |
Kras的共价抑制剂
|
WO2019084271A1
(en)
|
2017-10-25 |
2019-05-02 |
Children's Medical Center Corporation |
PAPD5 INHIBITORS AND METHODS OF USE
|
GB201718285D0
(en)
|
2017-11-03 |
2017-12-20 |
Discuva Ltd |
Antibacterial Compounds
|
JP2021035913A
(ja)
|
2017-12-21 |
2021-03-04 |
石原産業株式会社 |
N−メトキシアミド化合物又はその塩、及びそれらを含有する農園芸用殺菌剤
|
EP3737362A1
(en)
|
2018-01-12 |
2020-11-18 |
Kdac Therapeutics, Inc. |
Combination of a selective histone deacetylase 3 (hdac3) inhibitor and an immunotherapy agent for the treatment of cancer
|
JP2019168611A
(ja)
|
2018-03-23 |
2019-10-03 |
株式会社Adeka |
光学フィルタ
|
US20210093591A1
(en)
|
2018-03-30 |
2021-04-01 |
San Diego State University (SDSU) Foundation, dba San Diego State University Research Foundation |
Methods for mitigating and preventing proteostasis-based injuries
|
UA127357C2
(uk)
|
2018-04-18 |
2023-07-26 |
Констеллатіон Фармацеутікалс, Інк. |
Модулятори метилмодифікуючих ферментів, композиції та їх використання
|